Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Oncotarget|July 5, 2016
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagusDaniela Cabibi, Stefano Caruso, Viviana Bazan, et al.
Cancers|February 10, 2024
Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer PatientsNicola Gentili, William Balzi, Flavia Foca, et al.
Frontiers in Endocrinology|April 14, 2018
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?Sara Bravaccini, Sara Ravaioli, Dino Amadori, et al.
BMC Cancer|March 29, 2018
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?Giuseppe Bronte, Andrea Rocca, Sara Ravaioli, et al.
Expert Opinion on Biological Therapy|December 10, 2013
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?Giuseppe Bronte, Giuseppe Cicero, Giovanni Sortino, et al.
Oncotarget|September 30, 2015
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysisBruno Vincenzi, Margherita Nannini, Elena Fumagalli, et al.
Cardiovascular Diabetology|July 13, 2024
DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetesJacopo Sabbatinelli, Angelica Giuliani, Katarzyna Malgorzata Kwiatkowska, et al.
Analytical Cellular Pathology (Amsterdam)|October 21, 2015
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Daniele Fanale, Giuseppe Bronte, Francesco Passiglia, et al.
Journal of Clinical Medicine|April 11, 2020
Concomitant <i>TP53</i> Mutation Confers Worse Prognosis in <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIsMatteo Canale, Elisabetta Petracci, Angelo Delmonte, et al.
Therapeutic Advances in Medical Oncology|March 12, 2020
The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a <i>post hoc</i> analysis of the IBIS 3 trialSara Bravaccini, Giuseppe Bronte, Emanuela Scarpi, et al.
Pageof 11